{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:13:48Z","timestamp":1764922428297,"version":"3.46.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xkme.2025.101139","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:21:22Z","timestamp":1760145682000},"page":"101139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus (HCV) Recurrence and Death After Viral Clearance in an HCV-Viremic Donor to HCV-Negative Kidney Recipient"],"prefix":"10.1016","volume":"7","author":[{"given":"Shengliang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerna","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan I.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2025.101139_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2020.11.014","article-title":"Hepatitis C viraemic organs in solid organ transplantation","volume":"74","author":"Weinfurtner","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101139_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2022.12.019","article-title":"Kidney transplantation from hepatitis C virus-infected donors to uninfected recipients: a systematic review for the KDIGO 2022 hepatitis C clinical practice guideline update","volume":"82","author":"Gordon","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101139_bib3","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2025.101139_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101139_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ekir.2021.11.022","article-title":"One-year outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) trial","volume":"7","author":"Sise","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1016\/j.xkme.2025.101139_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.xkme.2025.101139_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ekir.2023.04.018","article-title":"Longer-term clinical outcomes from the THINKER and EXPANDER trials of transplantation of HCV-RNA+ donor kidneys into hepatitis C virus-negative recipients","volume":"8","author":"Potluri","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.xkme.2025.101139_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jama.2022.12868","article-title":"Five-year allograft survival for recipients of kidney transplants from hepatitis C virus infected vs uninfected deceased donors in the direct-acting antiviral therapy era","volume":"328","author":"Schaubel","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.xkme.2025.101139_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajt.2022.11.005","article-title":"The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications","volume":"23","author":"Sutcliffe","year":"2023","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2025.101139_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2022.12.006","article-title":"Antiviral treatment failures after transplantation of organs from donors with hepatitis C infection: a report of 4 cases","volume":"82","author":"Steinbrink","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101139_bib11","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2025.101139_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.xkme.2025.101139_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugpo.2018.08.013","article-title":"Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: the SIMPLIFY study","volume":"62","author":"Cunningham","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952500175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952500175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:10:29Z","timestamp":1764922229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952500175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S259005952500175X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101139","relation":{},"ISSN":["2590-0595"],"issn-type":[{"type":"print","value":"2590-0595"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Virus (HCV) Recurrence and Death After Viral Clearance in an HCV-Viremic Donor to HCV-Negative Kidney Recipient","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101139"}}